- Scientific Programme
- Official Language
- Exhibition & Sponsoring
- General Information
- Social Programme
- Important Dates
- Download Center
Blood safety is now a major concern in Africa, not only because of the heavy burden of HIV / AIDS and the high prevalence of communicable diseases in blood, but also because of the high incidence of malaria illness or deficiency, and severe bleeding of various origins, which may require massive transfusions.
|The RAFTS wishes you "AKWABA" (AKWABA means "Welcome" in local languages) to CISTHA 2013|
The quality and safety of blood products including blood products (LBP) to direct therapeutic use are therefore based on :
- a rigorous implementation of activities in the collection, preparation, biological qualification of the donation and distribution and
- a process of quality including all partners and especially the blood donors, prescribers, health care facilities.
However, facilitated the provision of antiretroviral treatment in Africa should lead to the medical management of a growing number of patients infected with HIV and increased risk of invasive procedures performed by care personnel upon release measures security.
There is a need to share knowledge and experiences in preventing and reducing the AES transfusion risk in blood transfusion activities in African countries and around the world. This need and the international character of accidental exposure to blood and viral transmission by blood transfusion are the reasons to initiate a global conference on this important subject.
It is a pleasure for us to invite you to Abidjan in Ivory Coast for the 2nd International Conference on Blood Safety and Safety Surveillance (CISTHA) to be held from 14 to 18 October 2013.
|Pr Bernard Chanfreau, International Scientific Committee President||Dr Konaté Séidou, Organization Committee President|